Siemens Plans Shareholder Vote on Siemens Healthineers Spin-Off in February 2027
Published by Global Banking & Finance Review®
Posted on April 17, 2026
2 min readLast updated: April 17, 2026
Add as preferred source on GooglePublished by Global Banking & Finance Review®
Posted on April 17, 2026
2 min readLast updated: April 17, 2026
Add as preferred source on GoogleSiemens will hold a shareholder vote in February 2027 on a direct spin‑off of 30 % of its Siemens Healthineers shares, transferring them directly to Siemens AG shareholders, subject to regulatory approvals.

April 17 (Reuters) - Siemens said on Friday it planned a shareholder vote on a direct spin-off of Siemens Healthineers shares at its next shareholder meeting in February 2027.
The announcement follows substantial progress in both the separation and regulatory clarification processes, it said, with final confirmation on the latter still outstanding.
Siemens shareholders will receive Siemens Healthineers AG shares directly, the group added.
When announcing the multi-billion-euro transaction in November, Siemens had also considered holding an Extraordinary General Meeting this year to approve the decision.
Siemens currently holds 67% of Siemens Healthineers and plans to transfer 30% of that to its shareholders, thereby relinquishing its majority stake in the subsidiary.
"The separation process and the regulatory clarification process are well advanced, although final confirmation regarding regulatory issues is still pending," a statement said.
Siemens no longer considers medical technology such as X-ray machines or laboratory systems as part of its core business.
Siemens Healthineers was spun off into the stock market in 2018, but its parent retained a majority stake.
(Reporting by Alexander Huebner, Writing by Linda Pasquini and Matthias Williams, Editing by Friederike Heine)
Siemens plans to hold the shareholder vote at its next shareholder meeting in February 2027.
Siemens shareholders will receive Siemens Healthineers AG shares directly.
The spin-off follows substantial progress in both the separation and regulatory clarification processes.
Final confirmation on the regulatory clarification process is still outstanding.
The article was written by Linda Pasquini and edited by Friederike Heine.
Explore more articles in the Finance category
